Radcliffe Capital Management’s AfterNext HealthTech Acquisition Corp Warrants AFTR.WS Stock Holding History

Radcliffe Capital Management’s Portfolio AFTR.WS Stock Details AFTR.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-13,768	Closed	-$1.21K	–	554
2023 Q2	$1.21K	Hold	13,768	–	–	﹤0.01%	570
2023 Q1	$2.29K	Hold	13,768	–	–	﹤0.01%	666
2022 Q4	$138K	Hold	13,768	–	–	﹤0.01%	849
2022 Q3	$135K	Hold	13,768	–	–	﹤0.01%	1164
2022 Q2	$134K	Buy	13,768 +1,296	+10%	+$448	﹤0.01%	1215
2022 Q1	$121K	Buy	+12,472	New	+$6.77K	﹤0.01%	1204

Radcliffe Capital Management's AFTR.WS Position: Q3 2023 in Review

Radcliffe Capital Management sold out of AfterNext HealthTech Acquisition Corp Warrants (AFTR.WS) in Q3 2023, closing a stake of 13,768 shares — an estimated $1.21K sold.

Radcliffe Capital Management first reported a position in AFTR.WS in Q1 2022 and held it in 6 quarters. The position peaked at $138K in Q4 2022. 0 funds tracked by Wall St. Rank hold AFTR.WS as of Q3 2023.

Radcliffe Capital Management reported no remaining AfterNext HealthTech Acquisition Corp Warrants position as of Q3 2023 after selling out during the quarter.
Radcliffe Capital Management sold 13,768 AfterNext HealthTech Acquisition Corp Warrants shares in Q3 2023, an estimated $1.21K.
Radcliffe Capital Management first reported a position in AfterNext HealthTech Acquisition Corp Warrants in Q1 2022 and held it in 6 quarters.
Radcliffe Capital Management's AfterNext HealthTech Acquisition Corp Warrants position peaked at $138K in Q4 2022.
0 funds tracked by Wall St. Rank held AfterNext HealthTech Acquisition Corp Warrants as of Q3 2023.

Based on Radcliffe Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.